Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential. | Explor Target Antitumor Ther;4(3): 474-497, 2023. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential.

Jou, Eric.

Affiliation

Jou E; Queens' College, University of Cambridge, CB3 9ET Cambridge, UK.

Explor Target Antitumor Ther ; 4(3): 474-497, 2023.

Article in En | MEDLINE | ID: mdl-37455828

Key words

Tumour microenvironment; cancer therapy; cytokines; immunotherapy; oncology trials; preclinical models; targeted therapy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Explor Target Antitumor Ther Year: 2023 Document type: Article Affiliation country: United kingdom Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Explor Target Antitumor Ther Year: 2023 Document type: Article Affiliation country: United kingdom Country of publication: United States